Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 28, 2014; 20(44): 16630-16638
Published online Nov 28, 2014. doi: 10.3748/wjg.v20.i44.16630
Published online Nov 28, 2014. doi: 10.3748/wjg.v20.i44.16630
Advances in non-surgical management of primary liver cancer
Xiao Chen, Hai-Peng Liu, Mei Li, Department of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, Gansu Province, China
Xiao Chen, Hai-Peng Liu, Mei Li, Key Laboratory of Digestive System Tumors of Gansu Province, Lanzhou 730030, Gansu Province, China
Liang Qiao, Storr Liver Unit, Westmead Millennium Institute, Department of Medicine and Western Clinical School, University of Sydney, NSW 2145, Australia
Author contributions: Chen X contributed to the conception, design, and creation of the first draft; Liu HP and Li M assisted with manuscript writing, the reference search, and table generation; Qiao L made considerable language edits and revisions to the manuscript, and approved the final version for publication.
Correspondence to: Liang Qiao, MD, PhD, Storr Liver Unit, Westmead Millennium Institute, Department of Medicine and Western Clinical School, University of Sydney, Westmead, NSW 2145, Australia. liang.qiao@sydney.edu.au
Telephone: +61-2-86273534
Received: May 9, 2014
Revised: June 17, 2014
Accepted: July 22, 2014
Published online: November 28, 2014
Revised: June 17, 2014
Accepted: July 22, 2014
Published online: November 28, 2014
Core Tip
Core tip: In recent years, there has been considerable progress in the development of non-surgical management for unrespectable hepatocellular carcinoma. These therapeutic options, either alone or in combination, have been shown to control tumor growth, prolong patient survival, and improve quality of life to some extent. Some of these strategies have been extensively used in clinical practice as the preferred approaches for advanced primary liver cancer.